News | July 12, 2025
Evonik opens new medical device center in Shanghai
The company’s largest center for medical device applications, serving the entire Asian market
The company’s largest center for medical device applications, serving the entire Asian market
EBITDA before special items decreases to €4.08 billion (7.4%)
Rising demands and advancements in eye care drive growth
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME)
Regulatory filings underway for a third indication for darolutamide in prostate cancer, for finerenone in a common form of heart failure, and acoramidis in transthyretin amyloid
DOVBLERON marks the 13th addition to Innovent’s commercial portfolio
Innovent has granted Roche exclusive global rights to develop, manufacture and commercialize IBI3009
JB’s domestic business continued to out-perform the market with all our major brands posting strong growth
US Generics grew 5% to Rs. 467 Crores for the quarter
Subscribe To Our Newsletter & Stay Updated
